Jason Litten

Chief Tech/Sci/R&D Officer at GENELUX CORPORATION

52 year

Health Technology

Consumer Services

Profile

Jason B. Litten is Chief Medical Officer at Genelux Corp.
since 2026.
Formerly, Dr. Litten was Chief Medical Officer at Chimeric Therapeutics Ltd. (Australia) from 2022 to 2025, Chief Medical Officer at Artiva Biotherapeutics, Inc. from 2019 to 2022, Chief Medical Officer at Optera Therapeutics Corp.
in 2019, Vice President-Clinical Development at Juno Therapeutics, Inc. from 2016 to 2018, Vice President-Clinical Development at Clovis Oncology, Inc. Education includes a doctorate from Emory University and an undergraduate degree from Cornell University.

Jason Litten active positions

Companies	Position	Start
GENELUX CORPORATION	Chief Tech/Sci/R&D Officer	01/01/2026

All active positions of Jason Litten

Former positions of Jason Litten

Companies	Position	End
CHIMERIC THERAPEUTICS LIMITED	Chief Tech/Sci/R&D Officer	22/12/2025
ARTIVA BIOTHERAPEUTICS, INC.	Chief Tech/Sci/R&D Officer	05/06/2022
Optera Therapeutics Corp.	Chief Tech/Sci/R&D Officer	31/05/2019
JUNO THERAPEUTICS INC	Corporate Officer/Principal	30/04/2018
CLOVIS ONCOLOGY, INC.	Corporate Officer/Principal	-

See the detail of Jason Litten's experience

Training of Jason Litten

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jason Litten's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	8
Genelux Corp. Genelux Corp. Pharmaceuticals: MajorHealth Technology Manufactures and markets drugs and virus strains solutions	Health Technology
Emory University Emory University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Cornell University Cornell University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Clovis Oncology, Inc. Clovis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as an biopharmaceutical company that acquires, develops and commercializes innovative anti cancer agents	Health Technology
Juno Therapeutics, Inc. Juno Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company to treat cancer, HIV and cardiovascular diseases	Health Technology
Artiva Biotherapeutics, Inc. Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops natural killer cell-based therapies for patients suffering from autoimmune diseases and cancers	Health Technology
Chimeric Therapeutics Ltd. (Australia) Chimeric Therapeutics Ltd. (Australia) BiotechnologyHealth Technology Develops cell therapies for the tumors	Health Technology
Optera Therapeutics Corp.